What is the market valuation of CircRNA synthesis?

The market valuation of the CircRNA synthesis is USD 274.59 million in 2027.

How is the CircRNA synthesis industry size expected to evolve during the forecast period?

CircRNA Synthesis Market size was around USD 243.6 million in 2026 and is slated to grow at a 15.11% CAGR from 2027 to 2036, reaching USD 994.97 million by 2036.

How are stability advantages of circRNA accelerating shifts in therapeutic development pipelines?

Superior intracellular stability is making circRNA more attractive for durable protein expression applications. This is pushing developers toward preclinical and translational programs in vaccines and gene therapies, increasing demand for high-purity synthesis and sequence optimization services.

How is biotechnology investment shaping commercialization pathways in the circRNA synthesis market?

Rising biotech funding is shifting demand toward scale-ready and GMP-aligned synthesis solutions. Companies are moving from small experimental batches to longer-term supply partnerships supporting clinical development, manufacturing readiness, and regulatory progression of circRNA therapies.

Why are Reagents & Kits the largest segment in the CircRNA synthesis market?

Reagents & Kits held a 50.13% share in 2026 because they are essential, repeat-use inputs for circRNA synthesis, optimization, and validation, supporting continuous laboratory research and development activities.

Why is Drug Discovery the fastest-growing application in the CircRNA synthesis market?

Drug Discovery is expanding rapidly as organizations increase exploratory circRNA research, using flexible synthesis approaches to accelerate candidate evaluation, mechanism studies, and iterative experimental development.

Why does North America lead the CircRNA synthesis market?

North America leads with 47.83% share due to strong biotechnology research ecosystem, concentrated RNA innovation activity, and advanced synthesis and analytical infrastructure supporting therapeutic and preclinical applications.

What is driving Asia Pacific growth in the CircRNA synthesis market?

Asia Pacific grows at 17.7% CAGR driven by expanding biotechnology research capacity, rising RNA-based development activity, and broader adoption of advanced synthesis workflows across institutions.

Which companies dominate the CircRNA synthesis landscape?

Key players in the CircRNA synthesis market include GenScript Biotech Corporation (China), LGC Biosearch Technologies (United Kingdom), Creative Biogene (United States), Applied Biological Materials Inc. (Canada), GeneCopoeia, Inc. (United States), Creative Biolabs (United States), SBS Genetech Co., Ltd. (China), Guangzhou Geneseed Biotech Co., Ltd. (China), Amerigo Scientific (United States), VectorBuilder Inc. (United States).